home.social

#celltherapy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #celltherapy, aggregated by home.social.

  1. UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

  2. Could autologous cell therapy be a next option in treatment of diabetic kidney disease?

    Read the excellent blog post at NephJC

    nephjc.com/news/rilprencel-rea

    #CKD #Diabetes #DKD #Medicine #Nephrology #CellTherapy

  3. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  4. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  5. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  6. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  7. J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  8. J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  9. J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  10. For all my BMT and Cell Therapy buddies, let’s find each other #BMT #CellTherapy #Transplantation